Plus, news about Spine BioPharma, AbbVie, Novartis’ Leqvio, Novo Nordisk's Alhemo, TenNor Therapeutics, Vigonvita Life Sciences, Orchestra BioMed, I-Mab and Oculis:
United Therapeutics' $1B share repurchase plan: The
↧